A Novartis study using technology from Cambridge-UK based Vectura has shown rapid, sustained improvement in lung function and symptom relief in sufferers of chronic obstructive pulmonary disease (COPD), the companies have announced.

Innova Biosciences, the Cambridge UK-based inventor of Lightning-Link® –a world-leading antibody labelling technology – has been awarded a development of prototype grant c£210,000 by the Technology Strategy Board.

GlaxoSmithKline plc (GSK) is buying Cellzome for £61 million cash by hoovering up the shares in the company that it doesn’t already own.

Lab21, the Cambridge UK specialist in personalised medicine, appears to have unlocked a potential commercial goldmine.

Kevin Fitzgerald has stepped down as CEO of antibodies specialist F-star just as the company brings all its research resources into the Cambridge UK bio cluster.

Lab21, a Cambridge UK specialist in personalised medicine and clinical diagnostics, is ramping up operations in the US.

Phytopharm’s share price fell more than eight per cent when the Cambridge UK BiomedTech cluster company reported a disappointing pre-clinical study of its drug Myogane™ in glaucoma.

TAP Biosystems in the Cambridge UK technology cluster is collaborating with scientists at the Open University to produce 3D human CNS tissue models.

Isogenica, a Cambridge UK leader in protein engineering, has secured €700,000 for a new peptide research project.

Cambridge technology entrepreneur Chris Curry has devised a wireless sensor system that allows family to remotely monitor relatives living alone – without invading their privacy – and triggers alerts in the event of serious incidents.

Cambridge’s most prolific life sciences entrepreneur, Andy Richards, says the local cluster is attracting more cash and global kudos than at any time in its history.

Results of a new study show that technology from BlueGnome in Cambridge can offer “dramatic benefit to IVF success,” the UK company has revealed.

MedImmune in Cambridge UK is to develop a new molecule that will be at the heart of a new treatment for Alzheimer’s disease.

Asterand, the human tissues supplier to Big Pharma, has lost a buyer for one of the businesses it hoped to sell to pay major creditors.

Revolutionary inhaler technology created by Team Consulting in Cambridge will be unveiled at this month’s Respiratory Drug Delivery conference in Phoenix, Arizona (May 13– 17).

A life science industry consultancy based at the heart of the Cambridge UK biomedtech cluster is playing a major role advising manufacturers on new EU cosmetics regulation.